Hologic, Inc. (HOLX): Price and Financial Metrics


Hologic, Inc. (HOLX): $63.39

1.09 (+1.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HOLX POWR Grades


  • HOLX scores best on the Growth dimension, with a Growth rank ahead of 97.08% of US stocks.
  • The strongest trend for HOLX is in Growth, which has been heading up over the past 31 weeks.
  • HOLX's current lowest rank is in the Momentum metric (where it is better than 16.13% of US stocks).

HOLX Stock Summary

  • With a one year PEG ratio of 1.3, Hologic Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 7.37% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Hologic Inc is reporting a growth rate of 628.69%; that's higher than 96.77% of US stocks.
  • Revenue growth over the past 12 months for Hologic Inc comes in at 59.92%, a number that bests 90.89% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to HOLX, based on their financial statements, market capitalization, and price volatility, are IAC, BC, DGX, AEM, and PKI.
  • HOLX's SEC filings can be seen here. And to visit Hologic Inc's official web site, go to www.hologic.com.

HOLX Price Target

For more insight on analysts targets of HOLX, see our HOLX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $84.17 Average Broker Recommendation 1.41 (Moderate Buy)

HOLX Stock Price Chart Interactive Chart >

Price chart for HOLX

HOLX Price/Volume Stats

Current price $63.39 52-week high $85.00
Prev. close $62.30 52-week low $49.19
Day low $62.15 Volume 2,934,200
Day high $63.62 Avg. volume 2,231,731
50-day MA $67.46 Dividend yield N/A
200-day MA $70.38 Market Cap 16.24B

Hologic, Inc. (HOLX) Company Bio


Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.

HOLX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$63.39$109.62 76%

We started the process of determining a valid price forecast for Hologic Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Hologic Inc ranked in the 66th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 76.5% on a DCF basis. The most interesting components of our discounted cash flow analysis for Hologic Inc ended up being:

  • HOLX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 26.96% of tickers in our DCF set.
  • The weighted average cost of capital for the company is 9. This value is greater than merely 21.58% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%72%
1%74%
2%76%
3%77%
4%79%
5%81%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HOLX, try CVS, MOH, ANTM, ALXN, and IQV.


HOLX Latest News Stream


Event/Time News Detail
Loading, please wait...

HOLX Latest Social Stream


Loading social stream, please wait...

View Full HOLX Social Stream

Latest HOLX News From Around the Web

Below are the latest news stories about Hologic Inc that investors may wish to consider to help them evaluate HOLX as an investment opportunity.

Hologic (HOLX) Acessa Procedure Now Covered by Cigna Insurance

Hologic's (HOLX) Acessa procedure new coverage will further validate Laparoscopic Radiofrequency Ablation as a standard of care for uterine fibroids.

Yahoo | June 10, 2021

3 Growth Stocks That Could Be Headed for Trouble Once the Pandemic Ends

These businesses are running out of steam. Now may be the time to hit the sell button on their stocks.

Yahoo | June 9, 2021

Cigna Updates Medical Policy to Cover Hologic’s Acessa® Procedure, Expanding Access to Millions of Women Across the Country

Cigna Updates Medical Policy to Cover Hologic’s Acessa® Procedure, Expanding Access to Millions of Women Across the Country

Yahoo | June 3, 2021

New Fibroid Management Guidance from the American College of Obstetricians and Gynecologists Supports Laparoscopic Radiofrequency Ablation (Lap-RFA) as a Minimally Invasive, Uterine Preserving Treatment Option

New Fibroid Management Guidance from the American College of Obstetricians and Gynecologists Supports Laparoscopic Radiofrequency Ablation

Yahoo | May 24, 2021

Hologic (HOLX) Presents At 6th Annual Credit & Levearged Finance Virtual Conference - Slideshow

The following slide deck was published by Hologic, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | May 21, 2021

Read More 'HOLX' Stories Here

HOLX Price Returns

1-mo 0.94%
3-mo -10.44%
6-mo -14.53%
1-year 26.40%
3-year 63.63%
5-year 89.73%
YTD -12.96%
2020 39.49%
2019 27.03%
2018 -3.86%
2017 6.56%
2016 3.70%

Continue Researching HOLX

Want to see what other sources are saying about Hologic Inc's financials and stock price? Try the links below:

Hologic Inc (HOLX) Stock Price | Nasdaq
Hologic Inc (HOLX) Stock Quote, History and News - Yahoo Finance
Hologic Inc (HOLX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8332 seconds.